Accrelist (SGX:QZG) Debt-to-Equity : 0.20 (As of Sep. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Accrelist Debt-to-Equity?

Accrelist's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was S$1.81 Mil. Accrelist's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was S$0.78 Mil. Accrelist's Total Stockholders Equity for the quarter that ended in Sep. 2024 was S$13.14 Mil. Accrelist's debt to equity for the quarter that ended in Sep. 2024 was 0.20.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Accrelist's Debt-to-Equity or its related term are showing as below:

SGX:QZG' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.35 Max: 1.04
Current: 0.2

During the past 13 years, the highest Debt-to-Equity Ratio of Accrelist was 1.04. The lowest was 0.03. And the median was 0.35.

SGX:QZG's Debt-to-Equity is ranked better than
68.09% of 561 companies
in the Healthcare Providers & Services industry
Industry Median: 0.44 vs SGX:QZG: 0.20

Accrelist Debt-to-Equity Historical Data

The historical data trend for Accrelist's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accrelist Debt-to-Equity Chart

Accrelist Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.72

0.36

0.70

0.41

0.26

Accrelist Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															1.04	0.41	0.35	0.26	0.20

Competitive Comparison of Accrelist's Debt-to-Equity

For the Medical Care Facilities subindustry, Accrelist's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accrelist's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Accrelist's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Accrelist's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Accrelist Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Accrelist's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.392	+	1.01)	/	12.958
	=	0.26

Accrelist's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.806	+	0.78)	/	13.141
	=	0.20

Accrelist (SGX:QZG) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Accrelist Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Accrelist's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Accrelist Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Accrelist Ltd (SGX:QZG) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Ubi Crescent, Ubi Techpark, Lobby E No. 03-95, Singapore, SGP, 408564

Website

https://www.accrelist.com.sg

Accrelist Ltd is focused on the distribution of electronics components, plastic injection molding, mold design, and fabrication services. The company's segment comprises a Mechanical business unit (MBU), Aesthetic Medical Services (AMS), and others. Accrelist is focused on maintaining a diversified customer mix and product portfolio for MBU and EBU while continuing to expand upon the medical aesthetic products and services provided to consumers. it generates a vast majority of revenue from the MBU segment.

Accrelist Headlines

No Headlines